Farid Manshadi, MD
Physical Medicine & Rehabilitation · Waterloo, IANPI 1033197165
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Lilly USA, LLC at 37.4% of the total. Reporting peaked in 2019 at $164 and has fallen 82.3% since, to $29 in 2023.
Across 36 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$191
- AbbVie$151
- Medtronic$43
- Piramal Critical Care$37
- Pfizer$29
- Collegium Pharmaceutical, Inc.$24
- plus $36 from 2 others
What the payments were for
- Food & beverage$512100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 13 | $191 |
| AbbVie(2 entities) | 11 | $151 |
| Medtronic | 3 | $43 |
| Piramal Critical Care | 2 | $37 |
| Pfizer | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $24 |
| Amgen | 2 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$512 in reported general payments places this provider in the 75th percentile of 58 physical medicine & rehabilitation providers in Iowa.
See all physical medicine & rehabilitation providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 26 | $148 |
| ClopidogrelClopidogrel Bisulfate | 16 | $117 |
| Carvedilol | 15 | $109 |
| Metformin Hcl | 12 | $95 |
| Losartan Potassium | 11 | $86 |
| Gabapentin | 12 | $83 |
| Amlodipine Besylate | 15 | $71 |
| Atorvastatin Calcium | 17 | $44 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Waterloo
- Alal UddinWaterloo$20
- Barbara Malicka-RozekWaterloo$0
- Neil SegalIowa City$2.2M
- Nicholas ApplebyCedar Rapids$49K
- Ryan KruseIowa City$8K
- Daniel GoldishNorth Liberty$6K
- Ai Huong PhuClive$6K
- Godfrey ThukuAmes$6K
- Anthony StarkDes Moines$4K
- Logan McCoolClive$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.